 |
|
| 鈥?/td>
| |
| 鈥?/td>
| |
| 鈥?/td>
| |
| 鈥?/td>
| |
|
| 鈥?/td>
| |
| 鈥?/td>
| |
| 鈥?/td>
| |
| 鈥?/td>
| |
| 鈥?/td>
| |
|
| 鈥?/td>
| |
| 鈥?/td>
| |
| 鈥?/td>
| |
| 鈥?/td>
| |
| 鈥?/td>
| |
| 鈥?/td>
| |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
Div. of Media Relations
1600 Clifton Road
MS D-14
Atlanta, GA 30333
(404) 639-3286
Fax (404) 639-7394 |
|
|
|
 |
For Immediate Release
May 4, 2006 |
Contact: CDC Media Relations
(404)-639-3286 |
CDC
Invests $10 million for Research
to Reduce Infections in Healthcare Settings
The Centers for Disease Control and Prevention (CDC) today announced an
award of $10 million for new research to five academic centers as part of
its Prevention Epicenter grant program, which supports efforts to develop
and test innovative approaches to reducing infections in healthcare settings.
CDC estimates that each year about 2 million infections are acquired in
healthcare settings, resulting in about 90,000 deaths and more than $4.5
billion in excess healthcare costs. With the emergence of drug-resistant
infections and new pathogens in healthcare settings, new strategies to detect
and reduce healthcare-associated infections become even more critical.
“We’re investing in these prevention epicenters because we
want to continue to improve patient health,” said Dr. Denise Cardo,
Director of CDC’s Division of Healthcare Quality and Promotion. “By
focusing on some of the most difficult and persistent problems facing healthcare
institutions today, these epicenters will help make healthcare safer for
everyone.”
Listed below are the names of the principal investigators and their institutions,
representing 58 affiliated hospitals:
Matthew Samore, M.D., University of Utah, Salt Lake City, Utah
Victoria Fraser, M.D., Washington University, St. Louis, Missouri
Kurt B. Stevenson, M.D., M.P.H, The Ohio State University, Columbus, Ohio
Richard Platt, M.D., Harvard Pilgrim Healthcare, Boston, Massachusetts
Robert Weinstein, M.D., Cook County Bureau of Health Services and Rush University
Medical Center, Chicago, Illinois
CDC began the Prevention Epicenter program in 1997 to promote new ways
to address difficult problems such as reducing the burden of healthcare-associated
infections and antibiotic resistance. CDC names new prevention epicenters
every five years based on peer-reviewed grant applications. The prevention
epicenters select and collaborate on joint research projects.
In recent years, the work of prevention epicenters has advanced knowledge
on improving judicious antimicrobial use in hospitals, understanding and
preventing the transmission of antimicrobial resistant organisms in hospitals,
developing better ways to identify infections following surgery and preventing
catheter-associated bloodstream infections among patients.
For more information about CDC’s Prevention Epicenters
please visit www.cy118119.com/ncidod/dhqp/epicenter.html
|
